Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Thursday broker round-up

Thu, 30th Apr 2015 18:01
Schroders: Credit Suisse reiterates outperform and 2,770p target price.Tesco: UBS restarts coverage at buy with 260p target.Pearson: Westhouse Securities reiterates sell and 1,185p target price.RBS: Shore Capital reiterates hold, Numis reiterates add (with 400p target), Investec reiterates hold (with 375p target), Credit Suisse reiterates underperform (with 320p target).Barclays: Nomura reiterates buy with 290p target, Canaccord Genuity reiterates buy and lifts target price to 288p from 280p.Standard Chartered: Berenberg reiterates hold but decreases target to 950p from 1000p.Antofagasta: Numis reiterates reduce and improves target to 700p from 600p.Supergroup: JP Morgan Cazenove reiterates overweight but shaves target price to 423p from 437p.Weir Group: Goldman Sachs reiterates buy and keeps target at 2,100p.London Stock Exchange: Bank of America reiterates buy and 2,950p target.IAG: Cantor Fitzgerald downgrades to sell but raises target to 520p from 470p.Rentokil Initial: UBS reiterates sell and takes target to 123p from 112p.Fisher (James) & Sons: Panmure Gordon reiterates buys and maintains 1,500p target.Shire: Charles Stanley reiterates accumulate.Royal Mail: Credit Suisse reiterates underperform and 370p target.Royal Dutch Shell: Credit Suisse reiterates outperform and 2,310p target.

Related News

Antofagasta agrees spot-indexed copper ore sales with some Chinese smelters, SMM says
14 hours ago

Antofagasta agrees spot-indexed copper ore sales with some Chinese smelters, SMM says

LONDON, July 1 (Reuters) - Chilean miner Antofagasta has ​agreed ⁠to sell term copper concentrate ​supplies to some Chinese smelters at spot-indexed p...

LONDON BROKER RATINGS: Deutsche ups RS to buy; Exane neutral on Segro
20 hours ago

LONDON BROKER RATINGS: Deutsche ups RS to buy; Exane neutral on Segro

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

South Africa's top court says bank rand-rigging case can proceed
21 hours ago

South Africa's top court says bank rand-rigging case can proceed

JOHANNESBURG, June 30 (Reuters) - South Africa's Constitutional Court ​ruled on Tuesday that competition authorities can pursue forex-rigging claims a...

Shire News

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push
6 Sep 2019

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms ...

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt
14 Aug 2019

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus ma...

Takeda kicks off sale of Western European drugs - sources
17 Jul 2019

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders fo...

Japan's Takeda expects binding offers for Latam business by end of May -sources
16 May 2019

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by...

Nikkei snaps 7-day losing streak helped by China's stimulus hopes
15 May 2019

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform B...

Nikkei hobbled by trade worries, disappointing earnings
15 May 2019

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earn...

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal
14 May 2019

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers ...

Japan's Takeda expects annual loss on Shire deal
14 May 2019

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books cost...